Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Vector-Borne and Zoonotic Disease - Researchers from University of Rhode Island report recent findings in vector-borne and zoonotic disease
West Nile Virus - Research from Australian National University yields new data on west nile virus
Bacillus Calmette-Guerin Vaccines - Research on Bacillus calmette-guerin vaccines described by scientists at Kuwait University, Department of Microbiology
HIV/AIDS Co-Infection Therapy - Findings in HIV/AIDS co-infection therapy reported from Royal Melbourne Hospital, Department of Respiratory Medicine
Influenza Vaccines - Research on influenza vaccines discussed by scientists at University of Washington
Legionnaire Disease - New research on legionnaire disease from Columbia University, Department of Microbiology summarized
Tuberculosis Genetics - New tuberculosis genetics research reported from University Nacional Autonoma of Mexico
Tuberculosis Therapy - Studies from National Taiwan University, Department of Internal Medicine yield new data on tuberculosis therapy
Bird Flu - Vaxart Awarded NIH Grant to Support Development of Orally-Delivered H5N1 Avian Influenza Vaccine
Blue Cross Blue Shield of Michigan - Blue Cross Blue Shield of Michigan and Blue Care Network Announce Interim Policy to Cover H1N1 Vaccine Administration for Fully-Insured Groups During 2009-2010 Flu Season
Healthscience Media Inc. - 1,500 Clinicians, 55 World-Renowned Clinical Experts, and 21 Medical Societies Convene in Boston for the 4th Annual Cardiometabolic Health Congress
Heart Disease - Philips launches new cardiograph to help clinicians deliver earlier diagnosis
HIV/AIDS - Most Pharmaceutical Companies Receive Poor Grades on HIV/AIDS Drug Development Innovation, According to AIDS Treatment Activist Coalition Report Card
Immunization - Americans Urged To Get Seasonal Influenza Vaccine Early
Immunization - COSHAR Foundation Promotes Importance of Timely Childhood Immunization at Black Family Reunion Celebration in Washington, D.C.
Immunization - LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
Immunization - School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign
Influenza - Hovione's TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza
Net Optics, Inc. - Net Optics Supports Worldwide Effort to Protect Businesses and Citizens Against Cyber Threats
Nuvilex, Inc. - Nuvilex, Inc. Announces Reme-Flu as Trade Name for All-Natural Flu Remedy Formula
Obesity and Diabetes - 16th and 17th U.S. Surgeons General, STOP Obesity Alliance Announce America has Reached Tipping Point on Obesity, Call for Direct Action
Pandemics - ViraCor-IBT Laboratories Launches Comprehensive Influenza and Respiratory Virus Testing Service; New suite of tests identifies 2009 Influenza a H1N1 (swine flu), additional influenza subtypes
Pharmaceuticals - IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting, Safety Concerns and Global Complexity
QIAGEN - QIAGEN Releases New Pandemic Influenza A/H1N1 Detection Kit
SunGard Availability Services - SunGard Availability Services to Present Avoiding Business Continuity Program Pitfalls at DRJ Fall World
Tuberculosis - World Debut for ASI's PathEx Suite: Line of Diagnostic Tools, Imaging and Information System for the Pathology Laboratory at the 22nd European Society of Pathology Meeting 2009
ENDPA
Type 1 Diabetes - Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes